Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor

NCT03558945 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Tumor

Interventions

BIOLOGICAL: Personalized neoantigen vaccine

Sponsor

Anda Biopharmaceutical Development (Shenzhen) Co., Ltd.